Kåre Schultz
2017
Compensation breakdown
| Option Awards | $2,000,009 |
|---|---|
| Salary | $333,333 |
| Stock Awards | $14,229,808 |
| Other | $464,591 |
| Total | $17,027,741 |
Schultz received $14.2M in stock awards, accounting for 84% of the total pay in 2017.
Schultz also received $2M in option awards, $333.3K in salary and $464.6K in other compensation.
Rankings
In 2017, Kåre Schultz's compensation ranked 217th out of 14,666 executives tracked by ExecPay. In other words, Schultz earned more than 98.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 217 out of 14,666 | 99th |
Division Manufacturing | 59 out of 5,772 | 99th |
Major group Chemicals And Allied Products | 17 out of 2,075 | 99th |
Industry group Drugs | 13 out of 1,731 | 99th |
Industry Pharmaceutical Preparations | 12 out of 1,333 | 99th |
Schultz's colleagues
We found nine more compensation records of executives who worked with Kåre Schultz at Teva Pharmaceutical Industries in 2017.
2017
Yitzhak Peterburg
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Rob Koremans
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Carlo de Notaristefani
Teva Pharmaceutical Industries
Executive Vice President, Global Operations
2017
Michael Hayden
Teva Pharmaceutical Industries
Chief Scientific Officer
2017
Eyal Desheh
Teva Pharmaceutical Industries
Chief Financial Officer
2017
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
2017
Erez Vigodman
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Mark Sabag
Teva Pharmaceutical Industries
Executive Vice President, Global Human Resources
2017
Michael McClellan
Teva Pharmaceutical Industries
Chief Financial Officer
News
April 13, 2022
April 21, 2021
April 22, 2020
April 16, 2019